Arch Therapeutics Inc
(OTCPK:ARTH)
$
0.21
-0.0698 (-24.95%)
Market Cap: 1.24 Mil
Enterprise Value: 10.69 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 28/100 Arch Therapeutics Inc at Ladenburg Thalmann Virtual Healthcare Conference Transcript
Jul 13, 2021 / 04:00PM GMT
Release Date Price:
$19.38
(-3.10%)
Michael Higgins
Ladenburg Thalmann & Company Inc. - Analyst
All right. Well, thank you, everyone, for joining us. My name is Michael Higgins, Managing Director, Senior Biotech Analyst here at Ladenburg Thalmann. Our next company to present is Arch Therapeutics. Joining us for this is Co-Founder, CEO, Terrence Norchi; as well as the recently joined CFO, Mike Abrams. I understand you guys have got some videos to show as well, so look forward to seeing that. And this is more of a fireside chat format, so I will be coming back in later and we will go through a few Q&As if that is good with you guys.
Terrence Norchi
Arch Therapeutics, Inc. - CEO
Sounds good. Thank you.
Mike Abrams
Arch Therapeutics, Inc. - CFO
Thank you.
Michael Higgins
Ladenburg Thalmann & Company Inc. - Analyst
All right, Terry, I will let you take it from here. Thank you, guys.
Terrence Norchi
Arch Therapeutics, Inc. - CEO
So thank you, Michael
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot